Traditional processes used to discover new materials are complex, time-consuming, and costly, often requiring years of sustained effort. Recent advances in large language models (LLMs) have ...
Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology SAN FRANCISCO--(BUSINESS WIRE)--#AstraZeneca--Multiply ...
The collaboration will focus on end-to-end robotic automation of industry-standard instruments used in cell therapy production sing Multiply Labs' robotic biomanufacturing system. The goal is to ...
Multiply Labs Inc. today announced an agreement with AstraZeneca to evaluate the potential for applying good manufacturing practice, or GMP-ready, robotic systems to commercial-scale cell therapy ...
A competition calling for research projects involving so-called AI scientists shows just how fast this technology is moving. A number of startups and university teams that are building “AI scientists” ...
INTEGRA Biosciences is inviting labs to leave manual pipetting behind and take their first steps into effortless automation with a new Lab Evolution competition for 2026. One forward-thinking ...
Most people still picture science as a person in a white coat, pipette in hand. That image is stubbornly accurate. Even in 2025—after decades of lab robots, high‑throughput screening, and cloud ...
SAN FRANCISCO, Calif., Jan. 12, 2026 — Multiply Labs, a leader in robotic biomanufacturing, announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is ...
Startups flush with cash are building AI-assisted laboratories to find materials far faster and more cheaply, but are still waiting for their ChatGPT moment. The microwave-size instrument at Lila ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results